002821 凯莱英
已收盘 07-09 15:00:00
资讯
新帖
简况
7月9日凯莱英涨7.82%，中欧医疗健康混合A基金重仓该股
证券之星 · 16:27
7月9日凯莱英涨7.82%，中欧医疗健康混合A基金重仓该股
凯莱英(06821)根据H股限制性股票计划授出合共2783.45万股激励股份
智通财经 · 07-08 22:08
凯莱英(06821)根据H股限制性股票计划授出合共2783.45万股激励股份
凯莱英（002821）披露2026年A股限制性股票激励计划（草案），7月8日股价下跌2.33%
证券之星 · 07-08 22:06
凯莱英（002821）披露2026年A股限制性股票激励计划（草案），7月8日股价下跌2.33%
凯莱英：第五届董事会第十一次会议决议的公告
证券日报 · 07-08 21:28
凯莱英：第五届董事会第十一次会议决议的公告
Norges Bank减持凯莱英(06821)20万股 每股作价约117.93港元
智通财经 · 07-08 19:25
Norges Bank减持凯莱英(06821)20万股 每股作价约117.93港元
Schroders PLC减持凯莱英(06821)8.07万股 每股作价108.42港元
智通财经网 · 07-06 19:24
Schroders PLC减持凯莱英(06821)8.07万股 每股作价108.42港元
凯莱英（002821）披露A股股份因购回并注销减少94,000股公告，7月3日股价上涨8.23%
证券之星 · 07-03
凯莱英（002821）披露A股股份因购回并注销减少94,000股公告，7月3日股价上涨8.23%
Norges Bank减持凯莱英(06821)39.71万股 每股作价约119.57港元
智通财经网 · 07-02
Norges Bank减持凯莱英(06821)39.71万股 每股作价约119.57港元
凯莱英创60日新高，开源证券二个月前给出“买入”评级
证券之星 · 06-29
凯莱英创60日新高，开源证券二个月前给出“买入”评级
港股CRO概念股涨幅居前 凯莱英涨10.69%
每日经济新闻 · 06-29
港股CRO概念股涨幅居前 凯莱英涨10.69%
创新药板块逆市大涨！凯莱英、海南海药等近十只涨停，多股涨超10%！_手机新浪网
中金财经 · 06-29
创新药板块逆市大涨！凯莱英、海南海药等近十只涨停，多股涨超10%！_手机新浪网
异动快报：凯莱英（002821）6月29日10点18分触及涨停板
证券之星 · 06-29
异动快报：凯莱英（002821）6月29日10点18分触及涨停板
股价异动，凯莱英称不存在应披露而未披露的重大事项
北京商报 · 06-25
股价异动，凯莱英称不存在应披露而未披露的重大事项
凯莱英：连续3个交易日收盘价涨幅偏离值累超20%
南方财经网 · 06-25
凯莱英：连续3个交易日收盘价涨幅偏离值累超20%
6月25日凯莱英涨6.99%，中欧医疗健康混合A基金重仓该股
证券之星 · 06-25
6月25日凯莱英涨6.99%，中欧医疗健康混合A基金重仓该股
凯莱英创60日新高，开源证券二个月前给出“买入”评级
证券之星 · 06-24
凯莱英创60日新高，开源证券二个月前给出“买入”评级
6月24日凯莱英（002821）涨停分析：大额订单落地、FDA检查通过、自研新药获批驱动
证券之星 · 06-24
6月24日凯莱英（002821）涨停分析：大额订单落地、FDA检查通过、自研新药获批驱动
CXO概念走强 凯莱英 (06821) 涨 17.77% BIO2026大会看好中国CXO高效率优势
金吾财讯 · 06-24
CXO概念走强 凯莱英 (06821) 涨 17.77% BIO2026大会看好中国CXO高效率优势
CRO概念股早盘表现强势 凯莱英涨超14%金斯瑞生物科技涨超8%
新浪港股 · 06-24
CRO概念股早盘表现强势 凯莱英涨超14%金斯瑞生物科技涨超8%
港股医药外包概念股走强 凯莱英涨超9%
每日经济新闻 · 06-24
港股医药外包概念股走强 凯莱英涨超9%
加载更多
公司概况
公司名称：
凯莱英医药集团(天津)股份有限公司
所属行业：
医药制造业
上市日期：
2016-11-18
主营业务：
凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是小分子CDMO解决方案、新兴业务。凯莱英生物AsymBio偶联药物开发平台成功入围第12届WorldADCAwards“BestADCPlatformTechnology”奖项，印证了凯莱英生物在全球抗体偶联药物CDMO领域的卓越地位。
发行价格：
30.53
{"stockData":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":161.23,"timestamp":1783580616000,"preClose":149.53,"halted":0,"volume":15446600,"delay":0,"changeRate":0.0782,"floatShares":317000000,"shares":361000000,"eps":3.0775,"marketStatus":"已收盘","change":11.7,"latestTime":"07-09 15:00:00","open":149.3,"high":163.31,"low":145.11,"amount":2429000000,"amplitude":0.1217,"askPrice":161.23,"askSize":15,"bidPrice":161.22,"bidSize":105,"shortable":0,"etf":0,"ttmEps":3.0775,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783647000000},"marketStatusCode":5,"adr":0,"adjPreClose":149.53,"symbolType":"stock","openAndCloseTimeList":[[1783560600000,1783567800000],[1783573200000,1783580400000]],"highLimit":164.48,"lowLimit":134.58,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":360780970,"isCdr":false,"pbRate":3.01,"roa":"--","peRate":52.389927,"roe":"1.71%","epsLYR":3.16,"committee":0.730858,"marketValue":58169000000,"turnoverRate":0.0487,"status":0,"hkstockBrief":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":115.3,"timestamp":1783584483007,"preClose":109.5,"halted":0,"volume":1021975,"delay":0,"premium":"-37.94"},"floatMarketCap":51117000000},"requestUrl":"/m/hq/s/002821","defaultTab":"news","newsList":[{"id":"2650942710","title":"7月9日凯莱英涨7.82%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650942710","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650942710?lang=zh_cn&edition=full","pubTime":"2026-07-09 16:27","pubTimestamp":1783585624,"startTime":"0","endTime":"0","summary":"证券之星消息，7月9日凯莱英涨7.82%，收盘报161.23元，换手率4.87%，成交量15.45万手，成交额24.29亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共67家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元，最新净值1.8455，较上一交易日下跌2.46%，近一年上涨7.42%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900028377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002821","159760","BK1191","BK0239","06821","BK0132","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649991153","title":"凯莱英(06821)根据H股限制性股票计划授出合共2783.45万股激励股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2649991153","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649991153?lang=zh_cn&edition=full","pubTime":"2026-07-08 22:08","pubTimestamp":1783519733,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，于2026年7月8日，根据H股限制性股票计划，本公司向若干雇员参与者授出合共2783.45万股激励股份(该授出)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002821","BK0132","LU1328615791.USD","06821","BK0239","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649499143","title":"凯莱英（002821）披露2026年A股限制性股票激励计划（草案），7月8日股价下跌2.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649499143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649499143?lang=zh_cn&edition=full","pubTime":"2026-07-08 22:06","pubTimestamp":1783519581,"startTime":"0","endTime":"0","summary":"截至2026年7月8日收盘，凯莱英报收于149.53元，较前一交易日下跌2.33%，最新总市值为539.48亿元。近日，凯莱英医药集团（天津）股份有限公司发布2026年A股限制性股票激励计划（草案），拟授予限制性股票338.80万股，占公司A股股本总额的1.02%，其中首次授予271.10万股，预留67.70万股。本计划有效期最长不超过72个月，解除限售期分为四个阶段，每期解除限售比例均为25%。业绩考核以2025年营业收入和净利润为基数，设定逐年增长目标。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800042532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002821","399300","BK0239","159982","06821","BK1191","BK0132","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649705999","title":"凯莱英：第五届董事会第十一次会议决议的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2649705999","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649705999?lang=zh_cn&edition=full","pubTime":"2026-07-08 21:28","pubTimestamp":1783517280,"startTime":"0","endTime":"0","summary":"证券日报网讯7月8日，凯莱英发布公告称，公司第五届董事会第十一次会议审议通过了《关于提请股东会授权董事会办理公司2026年A股限制性股票激励计划相关事宜的议案》等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607083798680184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","06821","BK1191","002821","LU1328615791.USD","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649998065","title":"Norges Bank减持凯莱英(06821)20万股 每股作价约117.93港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649998065","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649998065?lang=zh_cn&edition=full","pubTime":"2026-07-08 19:25","pubTimestamp":1783509943,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，7月6日，Norges Bank减持凯莱英(06821)20万股，每股作价117.9328港元，总金额约为2358.66万港元。减持后最新持股数目为266.6万股，持股比例为9.58%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464838.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002821","EWH","BK0132","LU1328615791.USD","ENOR","06821","BK1191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649302629","title":"Schroders PLC减持凯莱英(06821)8.07万股 每股作价108.42港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649302629","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649302629?lang=zh_cn&edition=full","pubTime":"2026-07-06 19:24","pubTimestamp":1783337049,"startTime":"0","endTime":"0","summary":"7月2日，Schroders PLC减持凯莱英(06821)8.07万股，每股作价108.42港元，总金额约为874.95万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260706/20260706192442_61945.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260706/20260706192442_61945.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1463684.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["002821","BK0239","BK1191","06821","EWH","LU1328615791.USD","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648666112","title":"凯莱英（002821）披露A股股份因购回并注销减少94,000股公告，7月3日股价上涨8.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648666112","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648666112?lang=zh_cn&edition=full","pubTime":"2026-07-03 22:17","pubTimestamp":1783088235,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，凯莱英报收于165.8元，较前一交易日上涨8.23%，最新总市值为598.17亿元。近日，凯莱英医药集团（天津）股份有限公司披露《证券变动月报表》。公告显示，截至2026年6月30日，公司A股已发行股份减少94,000股，系因购回并注销股份所致，涉及金额分别为36.42元和53.24元人民币；H股股份总数无变动；库存股数量未发生变化；公司确认H股公众持股量符合联交所规定的最低要求；本月底注册股本总额为人民币360,780,970元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300045631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","LU1328615791.USD","002821","BK0239","BK1191","399300","159982","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648040275","title":"Norges Bank减持凯莱英(06821)39.71万股 每股作价约119.57港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2648040275","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648040275?lang=zh_cn&edition=full","pubTime":"2026-07-02 19:07","pubTimestamp":1782990423,"startTime":"0","endTime":"0","summary":"香港联交所最新数据显示，6月29日，Norges Bank减持凯莱英(06821)39.71万股，每股作价119.5743港元，总金额约为4748.3万港元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260702/20260702190732_44536.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260702/20260702190732_44536.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1191","BK0132","BK0239","LU1328615791.USD","06821","EWH","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647386322","title":"凯莱英创60日新高，开源证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2647386322","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647386322?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:43","pubTimestamp":1782722609,"startTime":"0","endTime":"0","summary":"今日凯莱英创60日新高，收盘报167.75元。2026年4月1日，开源证券研究员余汝意发布了对凯莱英的研报《公司信息更新报告：收入利润高质增长，多赛道景气共振下迈向加速周期》，该研报对凯莱英给出“买入”评级。研报中预计2026-2028年公司归母净利润为15.07/18.59/23.12亿元，EPS为4.18/5.15/6.41元，当前股价对应PE为24.1/19.5/15.7倍，维持“买入”评级。凯莱英个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","161027","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647326829","title":"港股CRO概念股涨幅居前 凯莱英涨10.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647326829","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647326829?lang=zh_cn&edition=full","pubTime":"2026-06-29 14:38","pubTimestamp":1782715096,"startTime":"0","endTime":"0","summary":"6月29日，港股CRO概念股涨幅居前，截至发稿，凯莱英(06821.HK)涨10.69%，报123.2港元；昭衍新药(06127.HK)涨8.11%，报19.59港元；药明生物(02269.HK)涨6.9%，报35.32港元；药明康德(02359.HK)涨5.78%，报153.8港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606293786547646.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606293786547646.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["002821","06821","BK4585","BK0132","VXUS","LU1328615791.USD","BK0239","BK1191","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647347358","title":"创新药板块逆市大涨！凯莱英、海南海药等近十只涨停，多股涨超10%！_手机新浪网","url":"https://stock-news.laohu8.com/highlight/detail?id=2647347358","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647347358?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:34","pubTimestamp":1782700446,"startTime":"0","endTime":"0","summary":"创新药板块逆市大涨！凯莱英、海南海药等近十只涨停，多股涨超10%！ 分时图\r\n\r\n 创新药板块逆市大涨，凯莱英、海南海药、太龙药业、新华制药、双鹭药业等近十只涨停，新赣江逼近涨停，三生国健、益方生物、睿智医药、佰仁医疗、艾迪药业、荣昌生物、舒泰神、圣诺生物、百利天恒涨超10%，赛升药业、诺思兰德、康龙化成、贝达药业、诺诚健华跟涨。\r\n\r\n 消息面上，国家医保局6月29日对通过2026年目录初审的药品名单和主要信息进行公示，其中557个、54个药品分别通过基本医保药品目录、商保创新药目录初步形式审查。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202606/29/20260629655429.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202606/29/20260629655429.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/shichangceping/20260629/32292729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1191","BK0239","06821","000566","159992","LU1328615791.USD","BK0132","BK0146","002821","BK0188","BK1161","BK0070","06978","SINA","BK1574","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647134271","title":"异动快报：凯莱英（002821）6月29日10点18分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2647134271","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647134271?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:20","pubTimestamp":1782699656,"startTime":"0","endTime":"0","summary":"证券之星6月29日盘中消息，10点18分凯莱英（002821）触及涨停板。其所属行业医疗服务目前上涨。领涨股为万邦医药。该股为减肥药，创新药，健康中国概念热股，当日减肥药概念上涨5.43%，创新药概念上涨3.99%，健康中国概念上涨3.69%。6月26日的资金流向数据方面，主力资金净流出1.94亿元，占总成交额9.07%，游资资金净流出527.14万元，占总成交额0.25%，散户资金净流入1.99亿元，占总成交额9.32%。近5日资金流向一览见下表：凯莱英主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900008179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","06821","BK1191","002821","LU1328615791.USD","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646806264","title":"股价异动，凯莱英称不存在应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2646806264","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646806264?lang=zh_cn&edition=full","pubTime":"2026-06-25 21:58","pubTimestamp":1782395929,"startTime":"0","endTime":"0","summary":"由于6月23日至6月25日连续3个交易日内收盘价格涨幅偏离值累计超过20％，触发股价异动标准，6月25日晚间，凯莱英（002821）披露了公司股票交易异常波动公告。公告显示，经查询，公司、控股股东、实际控制人不存在关于公司的应披露而未披露的重大事项，也不存在处于筹划阶段的其他重大事项。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606253783373861.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606253783373861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["002821","BK0239","06821","BK1191","LU1328615791.USD","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646754438","title":"凯莱英：连续3个交易日收盘价涨幅偏离值累超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646754438","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646754438?lang=zh_cn&edition=full","pubTime":"2026-06-25 17:04","pubTimestamp":1782378240,"startTime":"0","endTime":"0","summary":"南财智讯6月25日电，凯莱英发布股票交易异常波动公告，公司股票于2026年6月23日至2026年6月25日连续3个交易日内收盘价格涨幅偏离值累计超过20%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606253783130288.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","06821","BK0132","BK0239","LU1328615791.USD","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646455873","title":"6月25日凯莱英涨6.99%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646455873","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646455873?lang=zh_cn&edition=full","pubTime":"2026-06-25 16:41","pubTimestamp":1782376913,"startTime":"0","endTime":"0","summary":"证券之星消息，6月25日凯莱英涨6.99%创60日新高，收盘报151.46元，换手率5.54%，成交量17.56万手，成交额25.78亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共67家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元，最新净值1.6918，较上一交易日上涨3.89%，近一年上涨0.44%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500029755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","159760","002821","LU1328615791.USD","BK0132","BK1191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645952898","title":"凯莱英创60日新高，开源证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2645952898","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645952898?lang=zh_cn&edition=full","pubTime":"2026-06-24 16:45","pubTimestamp":1782290722,"startTime":"0","endTime":"0","summary":"今日凯莱英创60日新高，收盘报141.57元。2026年4月1日，开源证券研究员余汝意发布了对凯莱英的研报《公司信息更新报告：收入利润高质增长，多赛道景气共振下迈向加速周期》，该研报对凯莱英给出“买入”评级。研报中预计2026-2028年公司归母净利润为15.07/18.59/23.12亿元，EPS为4.18/5.15/6.41元，当前股价对应PE为24.1/19.5/15.7倍，维持“买入”评级。凯莱英个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400030244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","06821","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645898450","title":"6月24日凯莱英（002821）涨停分析：大额订单落地、FDA检查通过、自研新药获批驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2645898450","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645898450?lang=zh_cn&edition=full","pubTime":"2026-06-24 15:43","pubTimestamp":1782287007,"startTime":"0","endTime":"0","summary":"证券之星消息，凯莱英6月24日涨停收盘，收盘价141.57元。该股于9点50分涨停，未打开涨停，截止收盘封单资金为9980.97万元，占其流通市值0.22%。6月24日凯莱英涨停的可能因素有：公司于6月21日公告与某跨国药企签署超2亿美元新订单，涉及临床阶段ADC药物CDMO服务；同期披露其天津新基地已通过FDA现场检查，产能释放预期强化；另据6月上旬披露，其子公司获CDE批准首个自主申报的1类新药临床批件，标志平台能力向创新延伸。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400023819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1328615791.USD","BK1191","002821","06821","BK0239","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645866019","title":"CXO概念走强 凯莱英 (06821) 涨 17.77% BIO2026大会看好中国CXO高效率优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2645866019","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645866019?lang=zh_cn&edition=full","pubTime":"2026-06-24 11:17","pubTimestamp":1782271026,"startTime":"0","endTime":"0","summary":"全球生物技术领域盛会BIO2026大会于6月22日至25日在美国圣地亚哥召开，汇聚全球超20000名行业参与者，覆盖人工智能与数字健康、细胞与基因治疗等前沿领域，中国CXO企业的高效率优势备受关注。光大证券研报指，2026年6月22日至25日BIO2026大会举办，70余个国家超2万名业内人士参会，覆盖18大生物医药核心议题，凯莱英、泰格医药、博腾股份等国内CXO企业参展，英硅智能同期落地AI药物研发海外合作。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984377","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","LU0359202008.SGD","002821","BK1576","02269","LU0052750758.USD","LU0348766576.USD","LU0516422366.SGD","LU1328615791.USD","06821","BK1583","LU0708995583.HKD","LU0359201612.USD","LU1794554557.SGD","03759","LU0856984785.SGD","LU2039709279.SGD","LU2242644610.SGD","LU0572944931.SGD","LU0326950275.SGD","SG9999002463.SGD","LU0819121731.USD","CXO","LU0516422952.EUR","HK0000320264.USD","BK1521","LU0588546209.SGD","LU0456827905.SGD","01548","HK0000320223.HKD","06127","LU1242518931.SGD","BK0132","LU1046422090.SGD","LU0320764599.SGD","LU0051755006.USD","03347","BK0239","HK0000306701.USD","LU0140636845.USD","HK0000306685.HKD","LU0348735423.USD","LU1720050803.USD","LU0327786744.USD","LU0039217434.USD","02359","LU0043850808.USD","LU3063872942.SGD","LU0456846285.SGD","LU1880383366.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645865054","title":"CRO概念股早盘表现强势 凯莱英涨超14%金斯瑞生物科技涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645865054","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645865054?lang=zh_cn&edition=full","pubTime":"2026-06-24 10:35","pubTimestamp":1782268500,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n CRO概念股早盘表现强势，截至发稿，凯莱英（06821）上涨14.05%，报110.40港元；金斯瑞生物科技（01548）上涨8.56%，报11.80港元；药明康德（02359）上涨8.56%，报142港元；泰格医药（03347）上涨5.67%，报32.74港元。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-06-24/doc-inienpmx8299253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01548","HK0000306701.USD","BK1141","BK0239","BK1191","BK1583","LU1328615791.USD","HK0000306685.HKD","BK0132","HK0000320264.USD","06821","002821","HK0000320223.HKD","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645865839","title":"港股医药外包概念股走强 凯莱英涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645865839","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645865839?lang=zh_cn&edition=full","pubTime":"2026-06-24 09:50","pubTimestamp":1782265829,"startTime":"0","endTime":"0","summary":"6月24日，港股医药外包概念股走强，截至发稿，凯莱英(06821.HK)涨超9%，金斯瑞生物科技(01548.HK)涨6.53%，泰格医药(03347.HK)涨5.04%，昭衍新药(06127.HK)涨5.13%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606243780775996.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606243780775996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159718","002821","BK0239","06821","BK1191","LU1328615791.USD","BK0132"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783595558367,"stockEarnings":[{"period":"1week","weight":-0.0927},{"period":"1month","weight":0.3399},{"period":"3month","weight":0.2438},{"period":"6month","weight":0.4506},{"period":"1year","weight":0.7183},{"period":"ytd","weight":0.6229}],"compareEarnings":[{"period":"1week","weight":-0.0344},{"period":"1month","weight":0.0029},{"period":"3month","weight":0.0012},{"period":"6month","weight":-0.0363},{"period":"1year","weight":0.1354},{"period":"ytd","weight":0.0005}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"凯莱英医药集团(天津)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2016-11-18","address":"天津市滨海新区经济技术开发区洞庭三街6号","registeredCapital":"36078万元","survey":" 凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是小分子CDMO解决方案、新兴业务。凯莱英生物AsymBio偶联药物开发平台成功入围第12届WorldADCAwards“BestADCPlatformTechnology”奖项，印证了凯莱英生物在全球抗体偶联药物CDMO领域的卓越地位。","listedPrice":30.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,002821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}